Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

MEDIFAST Aktie

 >MEDIFAST Aktienkurs 
11.67 EUR    -3.4%    (Tradegate)
Ask: 11.95 EUR / 836 Stück
Bid: 11.82 EUR / 846 Stück
Tagesumsatz: 26 Stück
Realtime Kurs von 8 bis 22 Uhr!
MEDIFAST Aktie über LYNX handeln
>MEDIFAST Performance
1 Woche: -8,8%
1 Monat: -5,5%
3 Monate: +2,3%
6 Monate: -23,5%
1 Jahr: -40,6%
laufendes Jahr: -30,0%
>MEDIFAST Aktie
Name:  MEDIFAST DL-,001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US58470H1014 / 889384
Symbol/ Ticker:  MDF (Frankfurt) / MED (NYSE)
Kürzel:  FRA:MDF, ETR:MDF, MDF:GR, NYSE:MED
Index:  -
Webseite:  https://medifastinc.com/
Marktkapitalisierung:  130.44 Mio. EUR
Umsatz:  469.07 Mio. EUR
EBITDA:  9.58 Mio. EUR
Gewinn je Aktie:  -0.55 EUR
Schulden:  12.61 Mio. EUR
Liquide Mittel:  79.16 Mio. EUR
Umsatz-/ Gewinnwachstum:  -39.63% / -110.3%
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  0.28 / 0.67 / -
Gewinnm./ Eigenkapitalr.:  -1.29% / -3.32%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  MEDIFAST
Letzte Datenerhebung:  03.08.25
>MEDIFAST Eigentümer
Aktien: 10.99 Mio. St.
f.h. Aktien: -
Insider Eigner: -
Instit. Eigner: -
>MEDIFAST Peer Group

 
01.08.25 - 20:03
Medifast Q2 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
21.07.25 - 22:06
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025 (Business Wire)
 
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quarter ended June 30, 2025 on Monday, August 4, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on August 4, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https://viavid.webcasts.com/starthere.jsp?ei=1726298&tp_key=605c001a0f and will be archived online and available through November 3, 2025. To join via telephone, listeners may dial (201) 389-0879. A telephonic playback will be available from 8:30 p.m. ET, August 4, 2025, through August 11, 2025. P...
18.06.25 - 05:01
Insiderhandel: Chairman & CEO kauft Aktien von MEDIFAST im Wert von 5003 USD (Insiderkauf)
 
Chard, Daniel R. - Vorstand - Tag der Transaktion: 2025-06-13...
28.05.25 - 19:00
Medifast (MED) Up 10.9% Since Last Earnings Report: Can It Continue? (Zacks)
 
Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
29.04.25 - 00:09
Medifast projects Q2 2025 revenue of $85M-$105M amid coach strategy enhancements (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.04.25 - 22:09
Medifast Announces First Quarter 2025 Financial Results (Business Wire)
 
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025. First Quarter 2025 Revenue of $115.7 million, with revenue per active earning coach of $4,556 Independent active earning OPTAVIA coaches of 25,400 Net loss of $0.8 million, which includes an unrealized gain on investment in LifeMD (Nasdaq: LFMD) common stock of $0.4 million (net of tax) Loss per share of $0.07 Cash, Cash Equivalents, and Investment Securities of $164.6 million with no debt "In today's health and wellness landscape, more people than ever are seeking guidance not just for weight loss but for learning how to lead a healthier lifestyle," said Dan Chard, CEO of Medifast. "However, research we commissioned indicates that 83% of those looking to lose weight lack confidence in their ability to transition to a healthy lifestyle for long-term health and wellness i...
15.04.25 - 19:00
Medifast Trades Near 52-Week Low: What′s the Best Move Now? (Zacks)
 
MED faces steep revenue declines and coach losses but aims to rebound through innovation, marketing and new GLP-1-focused initiatives....
14.04.25 - 22:06
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025 (Business Wire)
 
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quarter ended March 31, 2025 on Monday, April 28, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on April 28, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https://viavid.webcasts.com/starthere.jsp?ei=1712969&tp_key=ee624f7cf7 and will be archived online and available through July 28, 2025. To join via telephone, listeners may dial (201) 389-0879. A telephonic playback will be available from 8:30 p.m. ET, April 28, 2025, through May 5, 2025. Partici...
19.02.25 - 19:45
MED Q4 Earnings Beat, Revenues Dip Y/Y on Lower Customer Acquisition (Zacks)
 
Medifast's Q2 results show challenges related to weak customer acquisition. However, it is prioritizing efforts to enhance coach productivity in the near term....
19.02.25 - 01:45
Medifast (MED) Q4 Earnings and Revenues Beat Estimates (Zacks)
 
Medifast (MED) delivered earnings and revenue surprises of 137.04% and 7.70%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?...
19.02.25 - 01:12
Medifast outlines 2025 priorities with plans for $15M-$20M cost savings and new product expansions (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.02.25 - 22:09
Medifast Announces Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
 
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Revenue of $119.0 million, with revenue per active earning coach of $4,391 Independent active earning OPTAVIA coaches of 27,100 Net income of $0.8 million (non-GAAP adjusted net income of $1.1 million) Earnings per diluted share ("EPS") of $0.07 (non-GAAP adjusted EPS of $0.10) Cash, Cash Equivalents, and Investment Securities of $162.3 million and no debt Full Year 2024 Revenue of $602.5 million Net income of $2.1 million (non-GAAP adjusted net income of $20.2 million) EPS of $0.19 (non-GAAP adjusted EPS of $1.84) “This past year was a pivotal year for Medifast, as we continued to transform our business to meet the changing nature of a health and wellness market that has been revolutionized by the rising acceptance of GLP-1 medications,...
04.02.25 - 22:09
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024 (Business Wire)
 
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2024 on Tuesday, February 18, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on February 18, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https://viavid.webcasts.com/starthere.jsp?ei=1705513&tp_key=7b87c842ba and will be archived online and available through May 18, 2025. To join via telephone, listeners may dial (201) 389-0879. A telephonic playback will be available from 8:30 p.m. ET, February 18, 2...
08.01.25 - 14:30
Medifast Launches OPTAVIA ASCEND for Weight Loss Management (Zacks)
 
MED's new OPTAVIA ASCEND product line combines high-protein meals, fiber-rich nutrients and personalized coaching....
04.12.24 - 18:49
Medifast (MED) Down 5.8% Since Last Earnings Report: Can It Rebound? (Zacks)
 
Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
02.12.24 - 16:33
Do Options Traders Know Something About Medifast (MED) Stock We Don′t? (Zacks)
 
Investors need to pay close attention to Medifast (MED) stock based on the movements in the options market lately....
19.11.24 - 17:18
How Should You Play Medifast Stock at a P/E Multiple of 17.6X? (Zacks)
 
MED is battling customer acquisition challenges and high SG&A costs, while its strategic growth efforts keep it well-positioned for long-term success....
05.11.24 - 13:33
MED Q3 Earnings Beat, Revenues Fall on Customer Acquisition Challenges (Zacks)
 
Medifast's Q3 results lower earnings and revenues, highlighting challenges in customer acquisition. Management issues soft guidance for the fourth quarter....
05.11.24 - 00:48
Medifast (MED) Beats Q3 Earnings and Revenue Estimates (Zacks)
 
Medifast (MED) delivered earnings and revenue surprises of 333.33% and 3.48%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?...
04.11.24 - 22:33
Medifast Non-GAAP EPS of $0.35, revenue of $140.16M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ridetur, chorda qui semper oberrat eadem - Ausgelacht wird der (Kitharaspieler), der immer bei derselben Saite danebengreift. - Quintus Flaccus Horaz
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!